|
The Specialty Benchmarking Task Force oversees and manages the Center’s specialty pharmaceutical supply chain benchmarking study. The results are reported in the annual edition of Specialty Pharmaceuticals: Facts, Figures and Trend.
The Specialty Trends book highlights trends found in the specialty healthcare supply chain and serves as an industry resource. Companies that contribute data as part of the benchmarking program receive complementary copies of the Specialty Trends book.
Task Force Objectives
- Develop comprehensive benchmarking surveys for specialty distributors and manufacturers;
- Review and validate aggregated benchmarking results to ensure accuracy; and
- Oversee content development and production of the Specialty Pharmaceuticals: Facts, Figures and Trends.
2010-2011 Task Force Roster
Chairman
Rolando DeCardenas
Vice President, General Manager, Oncology Rx
US Oncology Specialty, LP
Robin DeChristopher-Barrale
Manager, Pharmacy Relations, Commercial Operations
Cephalon Inc.
Jennifer Dolan
Principal
Dolan & Associates
Paul Furgal
Senior Director, Business Development
McKesson Specialty Core Solutions
Robert B. Glasgow
Senior Vice President, Commercial Solutions
AmerisourceBergen Drug Company
Jon Kafer
Vice President, Sales and Marketing
TEVA Health Systems
Ed Kawamura
Strategic Account Manager
Eisai Inc.
Greg Malham
Director, Business Development
Cardinal Health Specialty Pharmaceutical Distribution
Mark McClelland
Senior Account Manager, National Trade
Genentech Inc.
Bill Parks
Director, Trade Operations
Centocor Ortho Biotech Services LLC
Pamela Sauerwald
Group Director, Planning and Development, Supplier Management
IMS Health®
Mark Smith
Director Corporate Accounts, Specialty Pharmacy
Novartis-USNM
Tad Strong
Senior Director of Supplier Management
PSS World Medical, Inc.
Staff Liaisons
Karen Ribler
Executive Vice President & COO
Center for Healthcare Supply Chain Research
Anti-trust Policy
Anti-harassment Policy
|